Resources Contact Us Home Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE     Method for treating bacterial infection with novel 7-substituted-9-substituted amino 6-demethyl-6-deoxytetracyclines RE40086 Method for treating bacterial infection with novel 7-substituted-9-substituted amino 6-demethyl-6-deoxytetracyclines Patent Drawings: Inventor: Hlavka, et al. Date Issued: February 19, 2008 Application: 11/318,390 Filed: December 23, 2005 Inventors: Hlavka; Joseph J. (Tuxedo Park, NY) Sum; Phaik-Eng (Pomona, NY) Gluzman; Yakov (Upper Saddle River, NJ) Lee; Ving J. (Los Altos, CA) Ross; Adma A. (Airmont, NY) Assignee: Wyeth Holdings Corporation (Madison, NJ) Primary Examiner: Badio; Barbara P. Assistant Examiner: Attorney Or Agent: U.S. Class: 514/152 Field Of Search: 514/152 International Class: A61K 31/65 U.S Patent Documents: Foreign Patent Documents: 109 850; 901107; WO 84/01895; WO 89/02270 Other References: Chopra, Handbook of Experimental Pharmacology, vol. 78, pp. 317-392, Springer-Verlay (1985). cited by examiner. Levy, Antimicrobial Agents & Chemotherapy, vol. 33(8), pp. 1373-1374, (Aug. 1989). cited by examiner. Salyers, Molecular Microbiology, vol. 4(1), pp. 151-156 (1990). cited by examiner. Adamson et al., "Aplastic Anemia," Hematology 4.sup.th ed., Williams WJ et al, eds.; McGraw Hill, New York (1990) pp. 158-174. cited by other. Allen, "Minocycline," Ann. Intern. Med. 85:482-487 (1976). cited by other. Altemeier et al., "Intra-abdominal Abscesses," American Journal of Surgery 125:70-79 (1973). cited by other. Bell, "Oral Penicillins in the Treatment of Chronic Staphylococcal Osteomyelitis," Lancet 10:295-297 (1968). cited by other. Benitz et al., "Morphologic Effects of Minocycline in Laboratory Animals," Toxicol. Appl. Pharmacol. 11:150-170 (1967). cited by other. Bennion et al., "Gangrenous and Perforated Appendicitis with Peritonitis: Treatment and Bacteriology," Clinical Therapeutics 12(Suppl C):31-44 (1990). cited by other. Bocker et al., "Identification and Determination of the Principal Metabolites of Minocycline in Humans," J. Chromatogr. 568:363-374 (1991). cited by other. Bohnen et al., "Prognosis in Generalized Peritonitis. Relation to Cause and Risk Factors," Archives of Surgery 118:285-290 (1983). cited by other. Boothe et al., "6-Deoxytetracyclines, I. Chemical Modification by Electrophilic Substitution" J. Am. Chem. Soc., 82:1253-1254 (1960). cited by other. Bryant et al., "Increased Frequency of Doxycycline Side Effects," Pharmacotherapy 7:125-129 (1987). cited by other. Buyske et al., "Concentration and Persistence of Tetracycline and Chlortetracycline in Bone," J. Pharmacol. Exper. Ther. 130:150-156 (1960). cited by other. Ciancio et al., "An Evaluation of Minocycline in patients with Periodontal Disease", Journal of Periodontology 51:530-534 (1980). cited by other. Collins, "Cell-Free Synthesis of Proteins Coding for Mobilisation function of colE1 and Transportation" Gene 6:28-42 (1979). cited by other. Conte et al., "Steady-State Serum and Intrapulmonary Pharmacokinetics and Pharmacodynamics of Tigecycline," Int. J. Antimicrob. Agents 25(6):523-529 (2005). cited by other. Degenkolb et al., "Structural Requirements of Tetracycline-tet Repressor Interaction: Dermination of Equilibrium Binding Constants for Tetracycline Analogs with the Tet Repressor", Antimicrob. Agents Chemother. 35:1591-1595 (1991). cited by other. DeJonge et al., "Inhibition of Mitochondrial-Protein Synthesis in Rat Small-Intestinal Epithelium," Eur. J. Biochem. 32:356-364 (1973). cited by other. Dietz et al., "Comparative Toxicity and Carcinogenicity Studies of Tetracycline and Oxytetracycline in Rats and Mice," Fund. Appl. Toxicol. 17:335-346 (1991). cited by other. Entwistle et al. ",Reduction of Nitro-compounds", J. Chem. Soc. 1:443 (1977). cited by other. Fanning et al., "Distressing Side-effects of Minocycline Hydrochloride," Arch Intern Med. 136:761-762 (1976). cited by other. Feigin, "Clindamycin Treatment of Osteomyelitis and Septic Arthritis in Children," Pediatr. 55:213-223 (1975). cited by other. Fry et al., "Determinants of Death in Patients with Intraabdominal Abscess," Surgery 88:517-523 (1980). cited by other. Garrison, "Histamine, Bradykinin, 5-Hydroxytryptamine, and Their Antagonists," In: Gilman AG, Rall TW et al., eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics 8.sup.th ed. Elmsford, NY: Pergamon Press pp. 575-582 (1990). cited byother. Gibaldi et al., Pharmacokinetics, 2.sup.nd ed., "One-Compartment", Marcel Dekker, Inc., NY, 1982, pp. 1-43. cited by other. Gorbach, "Antimicrobial Prophylaxis for Appendectomy and Colorectal Surgery," Reviews of Infectious Diseases 13(Suppl 10):S815-S820 (1991). cited by other. Gugler et al., "Effects of Antacids on the Clinical Pharmacokinetics of Drugs. An Update," Clin. Pharmacokinet. 18:210-219 (1990). cited by other. Gump et al., "Side Effects of Minocycline: Different Dosage Regimen," Antimicrob Agents Chemother. 12:642-646 (1977). cited by other. Hlavka et al., "The 6-Deoxytetracyclines. III Electrophilipic and Nucleophilic Substitution", J. Am. Chem. Soc., 84:1426-1430 (1962). cited by other. Jonas et al., "Minocycline," Ther. Drug Monit. 4:137-145 (1982). cited by other. Kantrowitz et al., "Histamine-Mediated Myocardial Damage in Rabbits," J. Mol. Cell. Cardiol. 14:551-555 (1982). cited by other. King, "Animal Models in the Study of Vomiting," Can. J. Physiol. Pharmacol. 68:260-268 (1990). cited by other. Larock, Comprehensive Organic Transformations, VCH Publishers, 411-415, (1989). cited by other. Loeliger et al., "Reliability and Clinical Impact of the Normalization of the Prothrombin Times in Oral Anticoagulant Control", Thrombosis & Haemostasis 53:148-154 (1985). cited by other. MacDonald et al., "Pharmacokinetic Studies on Minocycline in Man," Clinical Pharmacology and Therapeutics 14:852-861 (1973). cited by other. Misgen, "Compatibilities and Incompatibilities of Some Intravenous Solution Admixtures", Am. J. Hosp. Pharm. 22:92-94 (1965). cited by other. Mitscher, "The Chemistry of the Tetracycline Antiobiotic", Marcel Dekker, Inc. Chapter 6.3, p. 172-173 and Chapter 2, p. 53-54, (1978). cited by other. Monnier et al., "Visual Compatibility of Heparin with Selected Intravenous Admixtures", ASHP Midyear Clinical Meeting, vol. 25, p. P-186E (Dec. 1990). cited by other. Mosdell et al., "Antibiotic Treatment for Surgical Peritonitis," Annals of Surgery 214:543-549 (1991). cited by other. Morrison et al., "Amines I. Preparation and Physical Properties", Organic Chemistry, 4.sup.th ed., pp. 894, 898-900, 902 (1983). cited by other. Nelis et al., "Metabolism of Minocyclinein Humans," Drug Metab Dispos. 10:142-146 (1982). cited by other. Noble et al., "Short-term Toxicity and Observations on Certain Aspects of the Pharmacology of a Unique Tetracycline-Minocycline," Toxicol. Appl. Pharmacol. 11:128-149 (1967). cited by other. Norden, "Lessons Learned from Animal Models of Osteomyelitis," Rev. Infect. Dis. 10:103-110 (1988). cited by other. Norden, "Experimental Chronic Staphylococcal Osteomyelitis in Rabbits: Treatment with Rifampin Alone and in Combination with Other Antimicrobial Agents," Rev. Infect. Dis. 5(Suppl 3):S491-494 (1983). cited by other. Norden et al., "Treatment of Experimental Chronic Osteomyelitis Due to Staphylococcus Aureus with Vancomycin and Rifampin," J. Infect. Dis. 147:352-357 (1983). cited by other. Norden et al., "Clindamycin Treatment of Experimental Chronic Osteomyelitis Due to Staphylococcus Aureus," J. Infect. Dis. 153:956-959 (1986). cited by other. Norden et al., "Treatment of Experimental Chronic Osteomyelitis Due to Staphylococcus Aureus with Ampicillin/Sulbactam," J. Infect. Dis. 161:52-53 (1990). cited by other. Pawelczyk et al., "Kinetics of Drug Decomposition Part 74.Kinetics of Degradation of Minocycline in Aqueous Solution", Pharmacol. Pharm. 34:409-421 (1982). cited by other. Pratt, Coupled TranScription-translation in Prokaryotic Cell-free Systems, Transcription and Translation, a Practical Approach, (B.D. Hames and S.J. Higgins, eds.) p. 179-209, IRL Press, Oxford-Washington, (1984). cited by other. Raasch,"Interaction of Oral Antibiotics and Common Chronic Medications" Geriatrics 42:69-74 (1987). cited by other. Remmers et al., "Some Observations on the Kinetics of the C.4 Epimerization of Tetracycline," J. Pharm. Sci. 52:752-756 (1963). cited by other. Robertson, "p-Aminophenyllacetic Acid", Org. Syn. Coll. 1:52 (1941). cited by other. Rissing, "Animal Models of Osteomyelitis: Knowledge, Hypothesis and Speculation," Infect. Dis. Clin. North Am. 4:377-390 (1990). cited by other. Skillman et al., "Respiratory Failure, Hypotension, Sepsis, and Jaundice. A Clinical Syndrome Associated with Lethal Hemorrhage from Acute Stress Ulceration of the Stomach," American Journal of Surgery 117:523-530 (1969). cited by other. Slama et al., "Oral Ciprofloxacin Therapy for Osteomyelitis Caused by Aerobic Gram Negative Bacilli," Am. J. Med. 82(Suppl 4A):259-261 (1987). cited by other. Solomkin et al., "Results of a Multicenter Trial Comparing Imipenem/Cilastatin to Tobramycin/Clindamycin for Intra-abdominal Infections," Annals of Surgery 212:581-591 (1990). cited by other. Spencer et al., "6-Deocytetracyclines,. V. 7,9-Disubstituted Products", J. Med. Chem. 6:405-407 (1963). cited by other. Sum et al., "Synthesis of Novel Tetracycline Derivatives with Substitution at the C-8 Position," Tetrahedron Letters vol. 35, No. 12, pp. 1835-1836 (1994). cited by other. Swenson et al. "The Bacteriology of Intra-abdominal Infections," Archives of Surgery 109:398-399 (1974). cited by other. Tapp et al., "Tetracycline Toxicity," Experientia 22:530-531 (1966). cited by other. Tice, "Outpatient Parenteral Antimicrobial Therapy for Osteomyelitis," Infect. Dis. Clin. North Am. 12:903-919 (1998). cited by other. Van Den Bogert et al., "Tissue distribution and Effects on Mitochondrial Protein Synthesis of Tetracyclines After Prolonged Continuous Intravenous Administration to Rats," Biochem. Pharmacol. 30:1706-1709 (1981). cited by other. Waldvogel, "Osteomyelitis," In Gorbach SL et al., eds. Infectious Diseases, Saunders, Philadelphia 1339-1344 (1988). cited by other. Westfall et al., "Formulation of a Stable Trace Element Solution for TPN" Am. J. Hosp. Pharm. 37:1620 (1980). cited by other. Watson, "Chloramphenicol Toxicity in Dogs," Research in Veterinary Science 23:66-69 (1977). cited by other. Williams et al., "Minocycline: Possible Vestibular Side-Effects," Lancet. 2:744-746 (1974). cited by other. Woodward, "m-Hydroxybenzaldehyde", Org. Syn. Coll. 3:453 (1955. cited by other. Yuen, et al., "Kinetics of Concomitatnt Degradation of Tetracycline to Epitetracycline to Epitetracycline, Anhydrotetracycline, and Epianhydrotetracycline in Acid Phosphate Solution", J. Pharm. Sci. 66:1648-1650 (1977). cited by other. Zubay, "In-vitro Synthesis of Protein in Microbial Systems", Ann. Rev. Genet. 7:267-287 (1973). cited by other. The Merck Index, Entries #2111 and 5936 10.sup.th Ed. (1983) pp. 300,301, & 869. cited by other. World Health Organization Technical Report Series 687:1-184 (1983). cited by other. Abstract: The disclosure is drawn to a method of using novel 7-substituted-9-(substituted amino)-6-demethyl-6-deoxytetracycline compounds to treat infections caused by a wide spectrum of bacterial organisms, including those which are resistant to tetracycline. Claim: We claim: 1. A method for the treatment or control of bacterial infections in warm-blooded animals which comprises administering to said animal a pharmacologically effective amount of a compoundof the formula: ##STR00222## wherein: X is selected from amino, NR.sup.1R.sup.2, or halogen; the halogen is selected from bromine, chlorine, fluorine or iodine; R.sup.1 is selected from hydrogen, methyl, ethyl, n-propyl, 1-methylethyl, n-butyl and1-methylpropyl; R.sup.2 is selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, and 1,1-dimethylethyl such that when X=NR.sup.1R.sup.2 and R.sup.1=hydrogen, R.sup.2=methyl, ethyl, n-propyl, 1-methylethyl,n-butyl, 1-methylpropyl, 2-methylpropyl or 1,1-dimethylethyl; and when R.sup.1=methyl or ethyl, R.sup.2=methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl or 2-methylpropyl; and when R.sup.1=n-propyl, R.sup.2=n-propyl, 1-methylethyl,n-butyl, 1-methylpropyl or 2-methylpropyl; and when R.sup.1=1-methylethyl, R.sup.2=n-butyl, 1-methylpropyl or 2-methylpropyl; and when R.sup.1=n-butyl, R.sup.2=n-butyl, 1-methylpropyl or 2-methylpropyl; and when R.sup.1=1-methylpropyl,R.sup.2=2-methylpropyl; R is selected from R.sup.4(CH.sub.2).sub.nCO-- or R.sup.4' (CH.sub.2).sub.nSO.sub.2--; and n=0-4; and when R=R.sup.4(CH.sub.2).sub.n CO-- and .[.n-0.]. .Iadd.n=0.Iaddend., R.sup.4 is selected from hydrogen; amino; monosubstituted amino selected from straight or branched (C.sub.1-C.sub.6)alkylamino, cyclopropylamino, cyclobutylamino, benzylamino or phenylamino; disubstituted amino selected from dimethylamino, diethylamino, ethyl(1-methylethyl)amino,monomethylbenzylamino, piperidinyl, morpholinyl, 1-imidazolyl, 1-pyrrolyl, 1-(1,2,3-triazolyl) or .[.4-(1,2,4triazolyl).]. .Iadd.4-(1,2,4-triazolyl).Iaddend.; straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl,1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl or 1,1-dimethylethyl; (C.sub.3-C.sub.6)cycloalkyl selected from cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl; a substituted (C.sub.3-C.sub.6)cycloalkyl group with substitution selected from(C.sub.1-C.sub.3)alkyl, cyano, amino or (C.sub.1-C.sub.3)acyl; (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; a substituted (C.sub.6-C.sub.10)aryl group with substitution selected from halo, (C.sub.1-C.sub.4)alkoxy,trihalo (C.sub.1-C.sub.3)-alkyl, nitro, amino, cyano, .[.(C.sub.1-C.sub.4)alkoxycarbonyl (C.sub.1-C.sub.3)alkylamino.]. (.Iadd.C.sub.1-C.sub.4)alkoxycarbonyl, .Iaddend.(.Iadd.C.sub.1-C.sub.3)alkylamino .Iaddend.or carboxy; (C.sub.7-C.sub.9) aralkylselected from benzyl, 1-phenylethyl, 2-phenylethyl or phenylpropyl; .alpha.-amino-(C.sub.1-C.sub.4)alkyl selected from aminomethyl, .alpha.-aminoethyl, .alpha.-aminopropyl or .alpha.-aminobutyl; carboxy (C.sub.2-C.sub.4)-alkylamino selected fromaminoacetic acid, .alpha.-aminobutyric acid or .alpha.-aminopropionic acid and the optical isomers thereof; (C.sub.7-C.sub.9)aralklamino; (C.sub.1-C.sub.4)alkoxycarbonylamino substituted (C.sub.1-C.sub.4) alkyl group; .alpha.-hydroxy(C.sub.1-C.sub.3)alkyl selected from hydroxymethyl, .alpha.-hydroxyethyl or .alpha.-hydroxy-1-methylethyl or .alpha.-hydroxypropyl; .alpha.-mercapto (C.sub.1-C.sub.3)alkyl selected from mercaptomethyl, .alpha.-mercaptoethyl,.alpha.-mercapto-1-methylethyl or .alpha.-mercaptopropyl; halo(C.sub.1-C.sub.3)alkyl group; a heterocycle selected from the group consisting of a five membered aromatic or saturated ring with one N, O, S or Se heteroatom optionally having a benzo orpyrido ring fused thereto, a five membered aromatic ring with two N, O, S, or Se heteroatoms optionally having a benzo or pyrido ring fused thereto, a six membered aromatic ring with one to three N, O, S or Se heteroatoms, or a six membered saturatedring with one or two N, O, S or Se heteroatoms and an adjacent appended O heteroatom; acyl or haloacyl group selected from acetyl, propionyl, chloroacetyl, trifluoroacetyl; (C.sub.3-C.sub.6) .[.cycloalcylcarbonyl.]. .Iadd.cycloalkylcarbonyl.Iaddend.,(C.sub.6-C.sub.10)aroyl selected from benzoyl or napthoyl; halo substituted (C.sub.6-C.sub.10)aroyl; (C.sub.1-C.sub.4) alkylbenzoyl, or (heterocycle)-carbonyl, the heterocycle as defined hereinabove; (C.sub.1-C.sub.4)alkoxycarbonyl selected frommethoxycarbonyl, ethoxycarbonyl, straight or branched .[.propoxylcarbonyl.]. .Iadd.propoxycarbonyl.Iaddend., straight or branched butoxycarbonyl or allyloxycarbonyl; vinyl or a substituted vinyl group with substitution selected from (C.sub.1-C.sub.3)alkyl, halogen, (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-napthyl, .beta.-naphthyl, halo(C.sub.1-C.sub.3)alkyl, or a substituted (C.sub.6-C.sub.10)aryl group with substitution selected from halo, (C.sub.1-C.sub.3)alkoxy,trihalo(C.sub.1-C.sub.3)alkyl, nitro, amino, cyano, (C.sub.1-C.sub.4)alkoxycarbonyl, (C.sub.1-C.sub.3)alkylamino or carboxy; (C.sub.1-C.sub.4)alkoxy group; C.sub.6-aryloxy selected from phenoxy or substituted phenoxy with substitution selected fromhalo, (C.sub.1-C.sub.4) alkyl, nitro, cyano, thiol, amino, carboxy, di(C.sub.1-C.sub.3)alkylamino; (C.sub.7-C.sub.10)aralkyloxy; vinyloxy or a substituted vinyloxy group with substitution selected from (C.sub.1-C.sub.4)alkyl, cyano, carboxy, or(C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; R.sup.aR.sup.bamino(C.sub.1-C.sub.4)alkoxy group, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl,.[.1methylethyl.]. .Iadd.1-methylethyl.Iaddend., n-butyl, 1-methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or .[.(CH.sub.2).sub.2 W(CH.sub.2).sub.2--.]. .Iadd.--(CH.sub.2).sub.2W(CH.sub.2).sub.2--.Iaddend. wherein W isselected from --N(C.sub.1-C.sub.3)alkyl, O, S, --NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3)alkyl; or R.sup.aR.sup.baminoxy group, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl,n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, or 1,1-dimethylethyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2 W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)alkyl, O, S, --NH, --NOB and Bis selected from hydrogen or (C.sub.1-C.sub.3)alkyl; and when R=R.sup.4 (CH.sub.2).sub.nCO-- and .[.n-1-4.]. .Iadd.n=1-4.Iaddend., R.sup.4 is selected from hydrogen; amino; straight or branched (C.sub.1-C.sub.4) alkyl group selected from methyl,ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl or 1,1-dimethylethyl; (C.sub.3-C.sub.6)cycloalkyl selected from cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl; a substituted (C.sub.3-C.sub.6)cycloalkyl group withsubstitution selected from (C.sub.1-C.sub.3)alkyl, cyano, amino or (C.sub.1-C.sub.3)acyl; (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; a substituted(C.sub.6-C.sub.10)-aryl group with substitution selected from halo,(C.sub.1-C.sub.4)-alkoxy, trihalo(C.sub.1-C.sub.3)alkyl, nitro, amino, cyano, (C.sub.1-C.sub.4)alkoxycarbonyl, (C.sub.1-C.sub.3)alkylamino or carboxy; (C.sub.7-C.sub.10)aralkyl; acyloxy or haloacyloxy group selected from acetyl, propionyl,chloroacetyl, trichloroacetyl, (C.sub.3-C.sub.6) cycloalkylcarbonyl, (C.sub.6-C.sub.10)aroyl selected from benzoyl or naphthoyl, halo substituted (C.sub.6-C.sub.10)aroyl, (C.sub.1-C.sub.4)alkylbenzoyl, or (heterocycle)-carbonyl, the heterocycle asdefined hereinabove; (C.sub.1-C.sub.4)alkoxy; C.sub.6-aryloxy selected from phenoxy or substituted phenoxy with substitution selected from halo, (C.sub.1-C.sub.4)alkyl, nitro, cyano, thiol, amino, carboxy, di(C.sub.1-C.sub.3)alkylamino; (C.sub.7-C.sub.10)aralkyloxy; (C.sub.1-C.sub.3)alkylthio group selected from methylthio, ethylthio, propylthio or allylthio; C.sub.6-arylthio group selected from phenylthio or substituted phenylthio with substitution selected from halo,(C.sub.1-C.sub.4)alkyl, nitro, cyano, thiol, amino, carboxy, di(C.sub.1-C.sub.3)alkylamino; C.sub.6-arylsulfonyl group selected from phenylsulfonyl or substituted phenylsulfonyl with substitution selected from halo, (C.sub.1-C.sub.4)alkoxy,trihalo(C.sub.1-C.sub.3) alkyl, nitro, amino, cyano, (C.sub.1-C.sub.4)alkoxycarbonyl, (C.sub.1-C.sub.3) alkylamino or carboxy; (C.sub.7-C.sub.8)aralkylthio group; a heterocycle as defined hereinabove; hydroxy; mercapto; mono- or di-straight orbranched chain (C.sub.1-C.sub.6)-alkylamino with the alkyl selected from methyl, ethyl, n-propyl, 1-methyethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, 2-methylbutyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 3-methylbutyl, n-hexyl,1-methylpentyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 2-methylpentyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl or 1-methyl-1-ethylpropyl; (C.sub.2-C.sub.5)azacycloalkyl group; a carboxy(C.sub.2-C.sub.4)alkylamino group with the carboxy alkyl selected fromaminoacetic acid, .alpha.-aminopropionic acid, .alpha.-aminobutyric acid and the optical isomers thereof; .alpha.-hydroxy(C.sub.1-C.sub.3)alkyl selected from hydroxymethyl, .alpha.-hydroxyethyl or .alpha.-hydroxy-1-methyethyl or .alpha.-hydroxypropyl; halo(C.sub.1-C.sub.3)alkyl group; acyl or haloacyl selected from acetyl, propionyl, chloroacetyl, trifluroacetyl; (C.sub.3-C.sub.6) cycloalkylcarbonyl; (C.sub.6-C.sub.10)aroyl selected from benzoyl or naphthoyl; halo substituted(C.sub.6-C.sub.10)aroyl; (C.sub.1-C.sub.4)alkylbenzoyl, or (heterocycle)carbonyl, the heterocycle as defined hereinabove; .[.(C.sub.1-C.sub.4)alkoxycarbonylamino, group.]. .Iadd.(C.sub.1-C.sub.4)alkoxycarbonylamino group .Iaddend.selected fromtert-butoxycarbonylamino, allyloxycarbonylamino, methoxycarbonylamino, ethoxycarbonylamino or propoxycarbonylamino; (C.sub.1-C.sub.4)alkoxycarbonyl group selected from methoxycarbonyl, ethoxycarbonyl, straight or branched propoxycarbonyl,allyloxycarbonyl or straight or branched butoxycarbonyl; R.sup.aR.sup.b-amino(C.sub.1-C.sub.4)alkoxy group wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl,1-methylpropyl, methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is .[.(CH).sub.m.]. .Iadd.(CH.sub.2).sub.m.Iaddend., m=2-6 or --(CH.sub.2).sub.2 W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)alkyl, O, S, --NH, --NOB, and B isselected from hydrogen or (C.sub.1-C.sub.3)alkyl; or R.sup.aR.sup.baminoxy group, wherein R.sup.aR.sup.b is straight or branched (C.sub.1-C.sub.4)-alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl orR.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)-alkyl, O, S, --NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3)alkyl, and when R=R.sup.4'(CH.sub.2).sub.nSO.sub.2-- and n=0 R.sup.4' is selected from amino; monosubstituted amino selected from straight or branched (C.sub.1-C.sub.6)alkylamino, cyclopropylamino, cyclobutylamino, benzylamino or phenylamino; disubstituted amino selected fromdimethylamino, diethylamino, ethyl(1-methylethyl)amino, monomethylbenzylamino, piperidinyl, morpholinyl, 1-imidazolyl, 1-pyrrolyl, 1-(1,2,3-triazolyl) or 4-(1,2,4-triazolyl); straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl,n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl or 1,1-dimethylethyl; (C.sub.3-C.sub.6) cycloalkyl selected from cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl; a substituted (C.sub.3-C.sub.6)cycloalkyl group with substitutionselected from (C.sub.1-C.sub.3)alkyl, cyano, amino or (C.sub.1-C.sub.3) acyl; (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; a substituted (C.sub.6-C.sub.10)aryl group with substitution selected from halo,(C.sub.1-C.sub.4)alkoxy, trihalo(C.sub.1-C.sub.3)-alkyl, nitro, amino, cyano, (C.sub.1-C.sub.4)alkoxycarbonyl, (C.sub.1-C.sub.3)alkylamino or carboxy; (C.sub.7-C.sub.9)aralkyl; halo(C.sub.1-C.sub.3)alkyl group; a heterocycle as defined hereinabove; R.sup.aR.sup.b amino (C.sub.1-C.sub.4)alkoxy group, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)-alkyl selected from methyl, ethyl, n-propyl, 1-methyl-ethyl, n-butyl, 1-methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is(CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2W--(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)alkyl, O, S, --NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3)-alkyl; or R.sup.aR.sup.b aminoxy group, whereinR.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methyl-propyl, or 2-methylpropyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2 W(CH.sub.2).sub.2--wherein W is selected from --N(C.sub.1-C.sub.3) alkyl, O, S, --NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3) alkyl; and when R=R.sup.4' (CH.sub.2).sub.nSO.sub.2-- and n=1-4, R.sup.4' is selected from hydrogen; straight or branched(C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, .[.1methylpropyl.]. .Iadd.1-methylpropyl.Iaddend., 2-methyl-propyl or 1,1-dimethylethyl; (C.sub.1-C.sub.4) carboxyalkyl; (C.sub.3-C.sub.6)cycloalkyl selected fromcyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl; a substituted (C.sub.3-C.sub.6) cycloalkyl group with substitution selected from (C.sub.1-C.sub.3) alkyl, cyano, amino or (C.sub.1-C.sub.3)-acyl; (C.sub.6-C.sub.10)aryl selected from phenyl,.alpha.-naphthyl or .beta.-naphthyl; a substituted (C.sub.6-C.sub.10)aryl group with substitution selected from halo, (C.sub.1-C.sub.4)alkoxy, tri-halo(C.sub.1-C.sub.3) alkyl, nitro, amino, cyano, (C.sub.1-C.sub.4) alkoxy-carbonyl, (C.sub.1-C.sub.3)alkylamino or carboxy; (C.sub.7-C.sub.9)aralkyl selected from benzyl, 1-phenylethyl, 2-phenylethyl or phenylpropyl; (C.sub.1-C.sub.4)alkoxy; C.sub.6-aryloxy selected from phenoxy or substituted phenoxy with substitution selected from halo,(C.sub.1-C.sub.3)alkyl, nitro, cyano, thiol, amino, carboxy, di(C.sub.1-C.sub.3) alkylamino; (C.sub.7-C.sub.10)aralkyloxy; R.sup.aR.sup.b amino (C.sub.1-C.sub.4) alkoxy wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)-alkyl selectedfrom methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2 W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)alkyl, O, S, --NH, or .[.NOB.]. .Iadd.--NOB .Iaddend.and B is selected from hydrogen or (C.sub.1-C.sub.3)alkyl; or R.sup.aR.sup.b aminoxy group, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl,1-methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)alkyl, O, S, --NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3)alkyl; (C.sub.1-C.sub.3) alkylthio selected from methylthio, ethylthio or n-propylthio; C.sub.6-arylthio selected from phenylthio or substituted phenylthio with substitution selected from halo, (C.sub.1-C.sub.3)alkyl, nitro, cyano, thiol, amino, carboxy,di(C.sub.1-C.sub.3)alkylamino; (C.sub.7-C.sub.8) aralkylthio; a heterocycle as defined hereinabove; hydroxy; mercapto; mono- or di- straight or branched (C.sub.1-C.sub.6)alkyl- amino group .Iadd.with .Iaddend.the alkyl selected from methyl, ethyl,n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, 2-methylbutyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 3-methylbutyl, n-hexyl, 1-methylpentyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 2-methylpentyl, 1,2-dimethylbutyl,1,3-dimethylbutyl or 1-methyl-1-ethylpropyl; halo (C.sub.1-C.sub.3) alkyl; acyl or haloacyl selected from acetyl, propionyl, chloro-acetyl, trifluoroacetyl; (C.sub.3-C.sub.6) cycloalkylcarbonyl; (C.sub.6-C.sub.10) aroyl selected from benzoyl ornaphthoyl; halo substituted (C.sub.6-C.sub.10)aroyl, (C.sub.1-C.sub.4) alkylbenzoyl, or (heterocycle) carbonyl, the heterocycle as defined hereinabove; (C.sub.1-C.sub.4)alkoxycarbonyl selected from methoxycarbonyl, ethoxycarbonyl, straight or branchedpropoxycarbonyl, allyloxycarbonyl or straight or branched butoxycarbonyl; R.sup.5 is selected from hydrogen; straight or branched (C.sub.1-C.sub.3) alkyl selected from methyl, .[.ethyl n-propyl.]. .Iadd.ethyl, n-propyl .Iaddend.or 1-methylethyl; (C.sub.6-C.sub.10) aryl selected from phenyl, .alpha.-naphthyl or.beta.-naphthyl; (C.sub.7-C.sub.9) aralkyl group; a heterocycle as defined hereinabove; or --(CH.sub.2).sub.nCOOR.sup.7 where n=0-4 and R.sup.7 is selected from hydrogen; straight or branched (C.sub.1-C.sub.3)alkyl group selected from methyl, ethyl,n-propyl or 1-methylethyl; or (C.sub.6-C.sub.10)aryl group selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; R.sup.6 is selected from hydrogen; straight or branched (C.sub.1-C.sub.3)alkyl group selected .[.form.]. .Iadd.from .Iaddend.methyl,ethyl, n-propyl or 1-methylethyl; (C.sub.6-C.sub.10)aryl group selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; (C.sub.7-C.sub.9)-aralkyl group; a heterocycle as defined hereinabove; or --(CH.sub.2).sub.nCOOR.sup.7' where n=0-4 and R.sup.7'is selected from hydrogen; straight or branched (C.sub.1-C.sub.3)alkyl selected from methyl, ethyl, n-propyl or 1-methylethyl; or (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; with the proviso that R.sup.5 andR.sup.6 cannot both be hydrogen; or R.sup.5 and R.sup.6 taken together are --(CH.sub.2).sub.2 W(CH.sub.2).sub.2-- wherein W is selected from (CH.sub.2).sub.q and q=0-1, --NH, .[.--N(C.sub.1-C.sub.3)--alkyl.]. .Iadd.--N(C.sub.1-C.sub.3)alkyl.Iaddend.,--N(C.sub.1-C.sub.4) alkoxy, oxygen, sulfur or substituted congeners selected from (L or D)proline, ethyl(L or D)prolinate, morpholine, pyrrolidine or piperidine; and the pharmacologically acceptable organic and inorganic salts or metal complexes. 2. A method for the treatment or control of bacterial infections in warm-blooded animals caused by bacteria having the TetM and TetK resistant determinants which comprises administering to said animal a pharmacologically effective amount of acompound of the formula: ##STR00223## wherein: X is selected from amino, NR.sup.1R.sup.2 or halogen; the halogen is selected from bromine, chlorine, fluorine or iodine; .[.is.]. R.sup.1 is selected from hydrogen, methyl, ethyl, n-propyl,1-methylethyl, n-butyl and 1-methylpropyl; R.sup.2 is selected from methyl, .[.ethyl n-propyl.]. .Iadd.ethyl, n-propyl.Iaddend., 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, and 1,1-dimethylethyl such that when X=NR.sup.1R.sup.2 andR.sup.1=hydrogen, R.sup.2=methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl or 1,1-dimethylethyl; and when R.sup.1=methyl or ethyl, R.sup.2=methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl or 2-methylpropyl; and when R.sup.1=n-propyl, R.sup.2=n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl or 2-methylpropyl; and when R.sup.1=1-methylethyl, R.sup.2=n-butyl, 1-methylpropyl or 2-methylpropyl; and when R.sup.1=n-butyl, R.sup.2=n-butyl, 1-methylpropyl or2-methylpropyl; and when R.sup.1=1-methylpropyl, R.sup.2=2-methylpropyl; R is selected from R.sup.4(CH.sub.2).sub.nCO-- or R.sup.4' (CH.sub.2).sub.nSO.sub.2--; and n=0-4; and when R=R.sup.4(CH.sub.2).sub.n CO-- and .[.n-0.]. .Iadd.n=0.Iaddend.,R.sup.4 is selected from hydrogen; amino; monosubstituted amino selected from straight or branched (C.sub.1-C.sub.6)alkylamino, cyclopropylamino, cyclobutylamino, benzylamino or phenylamino; disubstituted amino selected from dimethylamino,diethylamino, ethyl(1-methylethyl)amino, monomethylbenzylamino, piperidinyl, morpholinyl, 1-imidazolyl, 1-pyrrolyl, 1-(1,2,3-triazolyl) or 4-(1,2,4-triazolyl); straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl,1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl or 1,1-dimethylethyl; (C.sub.3-C.sub.6)cycloalkyl selected from cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl; a substituted (C.sub.3-C.sub.6)cycloalkyl group with substitution selected from(C.sub.1-C.sub.3)alkyl, cyano, amino or (C.sub.1-C.sub.3)acyl; (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; a substituted (C.sub.6-C.sub.10)aryl group with substitution selected from halo, (C.sub.1-C.sub.4)alkoxy,.[.trihalo(C.sub.1-C.sub.3)--alkyl.]. .Iadd.trihalo(C.sub.1-C.sub.3)alkyl.Iaddend., nitro, amino, cyano, .[.(C.sub.1-C.sub.4)alkoxycarbonyl (C.sub.1-C.sub.3)alkylamino.]. (.Iadd.C.sub.1-C.sub.4)alkoxycarbonyl, (C.sub.1-C.sub.3)alkylamino .Iaddend.orcarboxy; (C.sub.7-C.sub.9) aralkyl selected from benzyl, 1-phenylethyl, 2-phenylethyl or phenylpropyl; .alpha.-amino-(C.sub.1-C.sub.4)alkyl selected from aminomethyl, .alpha.-aminoethyl, .alpha.-aminopropyl or .alpha.-aminobutyl; carboxy(C.sub.2-C.sub.4)-alkylamino selected from aminoacetic acid, .alpha.-aminobutyric acid or .alpha.-aminopropionic acid and the optical isomers thereof; (C.sub.7-C.sub.9)aralkylamino; (C.sub.1-C.sub.4)alkoxycarbonylamino substituted (C.sub.1-C.sub.4)alkyl group; .alpha.-hydroxy(C.sub.1-C.sub.3)alkyl selected from hydromethyl, .alpha.-hydroxyethyl or .alpha.-hydroxy-1-methylethyl or .alpha.-hydroxypropyl; .alpha.-mercapto (C.sub.1-C.sub.3)alkyl selected from mercaptomethyl, .alpha.-mercaptoethyl,.alpha.-mercapto-1-methylethyl or .alpha.-mercaptopropyl; halo(C.sub.1-C.sub.3)alkyl group; a heterocycle selected from the group consisting of a five membered aromatic or saturated ring with one N, O, S or Se heteroatom optionally having a benzo orpyrido ring fused thereto, a five membered aromatic ring with two N, O, S, or Se heteroatoms optionally having a benzo or pyrido ring fused thereto, a six membered aromatic ring with one to three N, O, S or Se heteroatoms, or a six membered saturatedring with one or two N, O, S or Se heteroatoms and an adjacent appended O heteroatom; acyl or haloacyl group selected from acetyl, propionyl, chloroacetyl, trifluoroacetyl; .[.(C.sub.3-C.sub.6) cycloalcylcarbonyl.]. (.Iadd.C.sub.3-C.sub.6)cycloalkylcarbonyl.Iaddend., (C.sub.6-C.sub.10)aroyl selected from benzoyl or naphthoyl; halo substituted (C.sub.6-C.sub.10)aroyl; (C.sub.1-C.sub.4) alkylbenzoyl, or (heterocycle)-carbonyl, the heterocycle as defined hereinabove; (C.sub.1-C.sub.4)alkoxycarbonyl selected from methoxycarbonyl, ethoxycarbonyl, straight or branched .[.propoxylcarbonyl.]. .Iadd.propoxycarbonyl.Iaddend., straight or branched butoxycarbonyl or allyloxycarbonyl; vinyl or a substituted vinyl group withsubstitution selected from (C.sub.1-C.sub.3) alkyl, halogen, (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl, .beta.-naphthyl, halo(C.sub.1-C.sub.3)alkyl, or a substituted (C.sub.6-C.sub.10)aryl group with substitution selected from halo,(C.sub.1-C.sub.4)-alkoxy, trihalo(C.sub.1-C.sub.3)alkyl, nitro, amino, cyano, (C.sub.1-C.sub.4)alkoxycarbonyl, (C.sub.1-C.sub.3)alkylamino or carboxy; (C.sub.1-C.sub.4)alkoxy group; C.sub.6-aryloxy selected from phenoxy or substituted phenoxy withsubstitution selected from halo, (C.sub.1-C.sub.4) alkyl, nitro, cyano, thiol, amino, carboxy, di(C.sub.1-C.sub.3)alkylamino; (C.sub.7-C.sub.10)aralkyloxy; vinyloxy or a substituted vinyloxy group with substitution selected from (C.sub.1-C.sub.4)alkyl,cyano, carboxy, or (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; R.sup.aR.sup.bamino(C.sub.1-C.sub.4)alkoxy group, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl,n-propyl, .[.1methylethyl.]. .Iadd.1-methylethyl.Iaddend., n-butyl, 1-methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or .[.(CH.sub.2).sub.2 W(CH.sub.2).sub.2--.]. .Iadd.--(CH.sub.2).sub.2 W(CH.sub.2).sub.2--.Iaddend. wherein W is selected from --N(C.sub.1-C.sub.3)alkyl, O, S, --NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3)alkyl; or R.sup.aR.sup.b aminoxy group, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)alkyl selected frommethyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, or 1,1-dimethylethyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2 W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)alkyl, .[.O,S,.]. .Iadd.O, S, .Iaddend.--NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3)alkyl; and when R=R.sup.4 (CH.sub.2).sub.nCO-- and .[.n-1-4.]. .Iadd.n=1-4.Iaddend., R.sup.4 is selected from hydrogen; amino; straight or branched (C.sub.1-C.sub.4)alkyl group selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl,.[.,.]. 1-methylpropyl, 2-methylpropyl, cyclobutyl, cyclopentyl or cyclohexyl; a substituted (C.sub.3-C.sub.6)cycloalkyl group with substitution selected from(C.sub.1-C.sub.3)alkyl, cyano, amino or (C.sub.1-C.sub.3)acyl; (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .[..beta.-naphyhyl.]. .Iadd..beta.-naphthyl.Iaddend.; a substituted(C.sub.6-C.sub.10)aryl group with substitution selectedfrom halo, .[.(C.sub.1-C.sub.4)alkoxy.]. .Iadd.(C.sub.1-C.sub.4)alkoxy.Iaddend., trihalo(C.sub.1-C.sub.3)alkyl, nitro, amino, cyano, (C.sub.1-C.sub.4)alkoxycarbonyl, (C.sub.1-C.sub.3)alkylamino or carboxy; (C.sub.7-C.sub.10)aralkyl; acyloxy orhaloacyloxy group selected from acetyl, propionyl, chloroacetyl, trichloroacetyl, (C.sub.3-C.sub.6) cycloalkylcarbonyl, (C.sub.6-C.sub.10)aroyl selected from benzoyl or naphthoyl, halo substituted (C.sub.6-C.sub.10)aroyl, (C.sub.1-C.sub.4)alkylbenzyl or(heterocycle)-carbonyl, the heterocycle as defined hereinabove; (C.sub.1-C.sub.4)alkoxy; C.sub.6-aryloxy selected from phenoxy or substituted phenoxy with substitution selected from halo, (C.sub.1-C.sub.4)alkyl, nitro, cyano, thiol, amino, carboxy,di(C.sub.1-C.sub.3)alkylamino; (C.sub.7-C.sub.10)aralkyloxy; (C.sub.1-C.sub.3)alkylthio group selected from methylthio, ethylthio, propylthio or allylthio; C.sub.6-arylthio group selected from phenylthio or substituted phenylthio with substitutionselected from halo, (C.sub.1-C.sub.4)alkyl, nitro, cyano, thiol, amino, carboxy, di(C.sub.1-C.sub.3)alkylamino; .[.C.sub.6-arylsulfinyl.]. .Iadd.C.sub.6-arylsulfonyl .Iaddend.group selected from phenylsulfonyl or substituted phenylsulfonyl withsubstitution selected from halo, (C.sub.1-C.sub.4)alkoxy, trihalo(C.sub.1-C.sub.3)alkyl, nitro, amino, cyano, (C.sub.1-C.sub.4)alkoxycarbonyl, (C.sub.1-C.sub.3) alkylamino or carboxy; (C.sub.7-C.sub.8)aralkylthio group; a heterocycle as definedhereinabove; hydroxy; mercapto; mono- or di-straight or branched chain .[.(C.sub.1-C.sub.6)-alkylamino.]. .Iadd.(C.sub.1-C.sub.6)alkylamino .Iaddend.with the alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl,2-methylpropyl, 1,1-dimethylethyl, 2-methylbutyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 3-methylbutyl, n-hexyl, 1-methylpentyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 2-methylpentyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl or 1-methyl-1-ethylpropyl; (C.sub.2-C.sub.5)azacycloalkyl group; a carboxy(C.sub.2-C.sub.4)alkylamino group with the carboxy alkyl selected from aminoacetic acid, .alpha.-aminopropionic acid, .alpha.-aminobutyric acid and the optical isomers thereof; .alpha.-hydroxy(C.sub.1-C.sub.3)alkyl selected from hydroxymethyl, .alpha.-hydroxyethyl or .alpha.-hydroxy-1-methylethyl or .alpha.-hydroxypropyl; halo(C.sub.1-C.sub.3)alkyl group; acyl or haloacyl selected from acetyl, propionyl, chloroacetyl,trifluoroacetyl; (C.sub.3-C.sub.6) cycloalkylcarbonyl; (C.sub.6-C.sub.10)aroyl selected from benzoyl or naphthoyl; halo substituted (C.sub.6-C.sub.10)aroyl; (C.sub.1-C.sub.4)alkylbenzoyl, or (heterocycle)carbonyl, the heterocycle as definedhereinabove; .[.(C.sub.1-C.sub.4)alkoxycarbonylamino,.]. .Iadd.(C.sub.1-C.sub.4).Iaddend..Iadd.alkoxycarbonylamino .Iaddend. group selected from tert-butoxycarbonylamino, allyloxycarbonylamino, methoxycarbonylamino, ethoxycarbonylamino orpropoxycarbonylamino; (C.sub.1-C.sub.4)alkoxycarbonyl group selected from methoxycarbonyl, ethoxycarbonyl, straight or branched propoxycarbonyl, allyloxycarbonyl or straight or branched butoxycarbonyl; R.sup.aR.sup.b-amino(C.sub.1-C.sub.4)alkoxy groupwherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is .[.(CH).sub.mm=2-6.]. .Iadd.(CH.sub.2).sub.m.Iaddend.,.Iadd.m=2-6 .Iaddend. or .[.--(CH.sub.2).sub.2W(CH.sub.2).sub.2-wherein.]. .Iadd.--(CH.sub.2).sub.2W(CH.sub.2).sub.2--wherein .Iaddend.W is selected from --N(C.sub.1-C.sub.3)-alkyl, O, S, --NH, --NOB, and B is selected from hydrogen or(C.sub.1-C.sub.3)alkyl; or R.sup.aR.sup.baminoxy group, wherein R.sup.aR.sup.b is straight or branched (C.sub.1-C.sub.4)-alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl or R.sup.aR.sup.b is(CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)-alkyl, .[.O,S,.]. .Iadd.O, S, .Iaddend.--NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3)alkyl, and when R=R.sup.4'(CH.sub.2).sub.nSO.sub.2-- and n=0 R.sup.4' is selected from amino; monosubstituted amino selected from straight or branched (C.sub.1-C.sub.6)alkylamino, cyclopropylamino, cyclobutylamino, benzylamino or phenylamino; disubstituted amino selected fromdimethylamino, diethylamino, ethyl(1-methylethyl)amino, monomethylbenzylamino, piperidinyl, morpholinyl, 1-imidazolyl, 1-pyrrolyl, 1-(1,2,3-triazolyl) or 4-(1,2,4-triazolyl); straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl,n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl or 1,1-dimethylethyl; (C.sub.3-C.sub.6)cycloalkyl selected from cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl; a substituted (C.sub.3-C.sub.6)cycloalkyl group with substitutionselected from (C.sub.1-C.sub.3)alkyl, cyano, amino or (C.sub.1-C.sub.3) acyl; (C.sub.6-C.sub.10)aryl selected from phenyl, .Iadd..alpha.-naphthyl .Iaddend.or .beta.-naphthyl .[..beta.-naphthyl or B-naphthyl.]. ; a substituted (C.sub.6-C.sub.10)arylgroup with substitution selected from halo, (C.sub.1-C.sub.4)alkoxy, trihalo(C.sub.1-C.sub.3)alkyl, nitro, amino, cyano, (C.sub.1-C.sub.4)alkoxycarbonyl, (C.sub.1-C.sub.3)alkylamino or carboxy; (C.sub.7-C.sub.9)aralkyl; halo(C.sub.1-C.sub.3)alkylgroup; a heterocycle as defined hereinabove; R.sup.aR.sup.b amino (C.sub.1-C.sub.4)alkoxy group, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)-alkyl selected from methyl, ethyl, n-propyl, 1-methyl-ethyl, n-butyl, 1-methylpropyl, or2-methylpropyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2W--(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)alkyl, O, S, --NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3)-alkyl; or R.sup.aR.sup.baminoxy group, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methyl-propyl, or 2-methylpropyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or--(CH.sub.2).sub.2W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3) alkyl, O, S, --NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3) alkyl; and when R=R.sup.4' (CH.sub.2).sub.nSO.sub.2-- and n=1-4, R.sup.4' is selectedfrom hydrogen; straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methyl-propyl or 1,1-dimethylethyl; (C.sub.1-C.sub.4) carboxyalkyl; (C.sub.3-C.sub.6)cycloalkyl selected fromcyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl; a substituted (C.sub.3-C.sub.6) cycloalkyl group with substitution selected from (C.sub.1-C.sub.3)alkyl, cyano, amino or (C.sub.1-C.sub.3)-acyl; (C.sub.6-C.sub.10)aryl selected from phenyl,.alpha.-naphthyl or .beta.-naphthyl; a substituted (C.sub.6-C.sub.10)aryl group with substitution selected from halo, (C.sub.1-C.sub.4)alkoxy, tri-halo(C.sub.1-C.sub.3) alkyl, nitro, amino, cyano, (C.sub.1-C.sub.4)alkoxy-carbonyl, (C.sub.1-C.sub.3)alkylamino or carboxy; (C.sub.7-C.sub.9)aralkyl selected from benzyl, 1-phenylethyl, 2-phenylethyl or phenylpropyl; (C.sub.1-C.sub.4)alkoxy; C.sub.6-aryloxy selected from phenoxy or substituted phenoxy with substitution selected from halo,(C.sub.1-C.sub.3)alkyl, nitro, cyano, thiol, amino, carboxy, di(C.sub.1-C.sub.3) alkylamino; (C.sub.7-C.sub.10)aralkyloxy; R.sup.aR.sup.b amino (C.sub.1-C.sub.4) alkoxy, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)-alkyl selectedfrom methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)alkyl, O, S, --NH, or .[.NOB.]. .Iadd.--NOB .Iaddend.and B is selected from hydrogen or (C.sub.1-C.sub.3)alkyl; or R.sup.aR.sup.b aminoxy group, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl,1-methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)alkyl, O, S, --NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3)alkyl; (C.sub.1-C.sub.3) alkylthio selected from methylthio, ethylthio or n-propylthio; C.sub.6-arylthio selected from phenylthio or substituted phenylthio with substitution selected from halo, (C.sub.1-C.sub.3)alkyl, nitro, cyano, thiol, amino, carboxy,di(C.sub.1-C.sub.3)alkylamino; (C.sub.7-C.sub.8) aralkythio; a heterocycle as defined hereinabove; hydroxy; mercapto; mono- or di-straight or branched (C.sub.1-C.sub.6)alkyl- amino group .Iadd.with .Iaddend.the alkyl selected from methyl, ethyl,n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, 2-methylbutyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 3-methylbutyl, n-hexyl, 1-methylpentyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 2-methylpentyl, 1,2-dimethylbutyl,1,3-dimethylbutyl or 1-methyl-1-ethylpropyl; halo (C.sub.1-C.sub.3) alkyl; acyl or haloacyl selected from acetyl, propionyl, chloro-acetyl, trifluoroacetyl; (C.sub.3-C.sub.6) cycloalkylcarbonyl; (C.sub.6-C.sub.10) aroyl selected from benzoyl or naphthoyl; halo substituted (C.sub.6-C.sub.10)aroyl, (C.sub.1-C.sub.4)alkylbenzoyl, or (heterocycle) carbonyl, the heterocycle as defined hereinabove; (C.sub.1-C.sub.4)alkoxycarbonyl selected from methoxycarbonyl,ethoxycarbonyl, straight or branched propoxycarbonyl, allyloxycarbonyl or straight or branched butoxycarbonyl; R.sup.5 is selected from hydrogen; straight or branched (C.sub.1-C.sub.3)alkyl selected from methyl, .[.ethyl.]. .Iadd.ethyl,.Iaddend.n-propyl or 1-methylethyl; (C.sub.6-C.sub.10) aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; (C.sub.7-C.sub.9) aralkyl group; a heterocycle as defined hereinabove; or --(CH.sub.2).sub.nCOOR.sup.7 where n=0-4 and R.sup.7 isselected from hydrogen; straight or branched (C.sub.1-C.sub.3)alkyl group selected from methyl, ethyl, n-propyl or 1-methylethyl; or (C.sub.6-C.sub.10)aryl group selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; R.sup.6 is selected fromhydrogen; straight or branched (C.sub.1-C.sub.3)alkyl group selected .[.form.]. .Iadd.from .Iaddend.methyl, ethyl, n-propyl, or 1-methylethyl; (C.sub.6-C.sub.10)aryl group selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; (C.sub.7-C.sub.9)-aralkyl group; a heterocycle as defined hereinabove; or --(CH.sub.2).sub.nCOOR.sup.7' where n=0-4 and R.sup.7' is selected from hydrogen; straight or branched (C.sub.1-C.sub.3)alkyl selected from methyl, ethyl, n-propyl or1-methylethyl; or (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; with the proviso that R.sup.5 and R.sup.6 cannot both be hydrogen; or R.sup.5 and R.sup.6 taken together are --(CH.sub.2).sub.2W(CH.sub.2).sub.2--,wherein W is selected from (CH.sub.2).sub.q and q=0-1, --NH, --N(C.sub.1-C.sub.3)-alkyl, --N(C.sub.1-C.sub.4) alkoxy, oxygen, sulfur or substituted congeners selected from (L or D)proline, ethyl(L or D)prolinate, morpholine, pyrrolidine or piperidine; and the pharmacologically acceptable organic and inorganic salts or metal complexes. .Iadd.3. A method for the treatment or control of bacterial infections in warm-blooded animals which comprises administering to said animal a pharmacologically effective amount of a compound of the formula: ##STR00224## wherein: X is selectedfrom amino, NR.sup.1R.sup.2 or halogen; the halogen is selected from bromine, chlorine, fluorine or iodine; R.sup.1 is selected from hydrogen, methyl, ethyl, n-propyl, 1-methylethyl, n-butyl and 1-methylpropyl; R.sup.2 is selected from methyl, ethyl,n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, and 1,1-dimethylethyl such that when X=NR.sup.1R.sup.2 and R.sup.1=hydrogen, R.sup.2=methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl or 1,1-dimethylethyl; and when R.sup.1=methyl or ethyl, R.sup.2=methyl, ethyl, n-propyl, 1-methylethyl, n-methylpropyl or 2-methylpropyl; and when R.sup.1=n-propyl, R.sup.2=n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl or 2-methylpropyl; and when R.sup.1=1-methylethyl,R.sup.2=n-butyl, 1-methylpropyl or 2-methylpropyl; and when R.sup.1=n-butyl; R.sup.2=n-butyl, 1-methylpropyl or 2-methylpropyl; and when R.sup.1=1-methylpropyl, R.sup.2=2-methylpropyl; R is selected from R.sup.4(CH.sub.2).sub.nCO-- or R.sup.4'(CH.sub.2).sub.nSO.sub.2--; and n=0-4; and when R=R.sup.4(CH.sub.2).sub.n CO-- and n=0, R.sup.4 is selected from hydrogen; amino; monosubstituted amino selected from straight or branched (C.sub.1-C.sub.6)alkylamino, cyclopropylamino, cyclobutylamino,benzylamino or phenylamino; disubstituted amino selected from dimethylamino, diethylamino, ethyl(1-methylethyl)amino, monomethylbenzylamino, piperidinyl, morphonlinyl, 1-imidazolyl, 1-pyrrolyl, 1-(1,2,3-triazolyl) or 4-(1,2,4-triazolyl); straight orbranched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl or 1,1-dimethylethyl; (C.sub.3-C.sub.6)cycloalkyl selected from cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl; asubstituted (C.sub.3-C.sub.6)cycloalkyl group with substitution selected from (C.sub.1-C.sub.3)alkyl, cyano, amino or (C.sub.1-C.sub.3)acyl; (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; a substituted(C.sub.6-C.sub.10)aryl group with substitution selected from halo, (C.sub.1-C.sub.4) alkoxy, trihalo(C.sub.1-C.sub.3)alkyl, nitro, amino, cyano, (C.sub.1-C.sub.4)alkoxycarbonyl, (C.sub.1-C.sub.3)alkylamino or carboxy; (C.sub.7-C.sub.9) aralkyl selectedfrom benzyl, 1-phenylethyl, 2-phenylethyl or phenylpropyl; .alpha.-amino-(C.sub.1-C.sub.4)alkyl selected from aminomethyl, .alpha.-aminoethyl, .alpha.-aminopropyl or .alpha.-aminobutyl; carboxy (C.sub.2-C.sub.4)-alkylamino selected from aminoaceticacid, .alpha.-aminobutyric acid or .alpha.-aminopropionic acid and the optical isomers thereof; (C.sub.7-C.sub.9)aralkylamino; (C.sub.1-C.sub.4)alkoxycarbonylamino substituted (C.sub.1-C.sub.4) alkyl group; .alpha.-hydroxy(C.sub.1-C.sub.3)alkylselected from hydroxymethyl, .alpha.-hydroxyethyl or .alpha.-hydroxy-1-methylethyl or .alpha.-hydroxypropyl; .alpha.-mercapto (C.sub.1-C.sub.3)alkyl selected from mercaptomethyl, .alpha.-mercaptoethyl, .alpha.-mercapto-1-methylethyl or.alpha.-mercaptopropyl; halo(C.sub.1-C.sub.3)alkyl group; a heterocycle selected from the group consisting of a five membered aromatic or saturated ring with one N, O, S or Se heteroatom optionally having a benzo or pyrido ring fused thereto, a fivemembered aromatic ring with two N, O, S, or Se heteroatoms optionally having a benzo or pyrido ring fused thereto, a six membered aromatic ring with one to three N, O, S or Se heteroatoms, or a six membered saturated ring with one or two N, O, S or Seheteroatoms and an adjacent appended O heteroatom; acyl or haloacyl group selected from acetyl, propionyl, chloroacetyl, trifluoroacetyl; (C.sub.3-C.sub.6) cycloalkylcarbonyl, (C.sub.6-C.sub.10)aroyl selected from benzoyl or naphthoyl; halosubstituted (C.sub.6-C.sub.10)aroyl; (C.sub.1-C.sub.4) alkylbenzoyl, or (heterocycle)-carbonyl, the heterocycle as defined hereinabove; (C.sub.1-C.sub.4)alkoxycarbonyl selected from methoxycarbonyl, ethoxycarbonyl, straight or branched propoxycarbonyl,straight or branched butoxycarbonyl or allyloxycarbonyl; vinyl or a substituted vinyl group with substitution selected from (C.sub.1-C.sub.3) alkyl, halogen, (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl, .beta.-naphthyl,halo(C.sub.1-C.sub.3)alkyl, or a substituted (C.sub.6-C.sub.10)aryl group with substitution selected from halo, (C.sub.1-C.sub.4)-alkoxy, trihalo(C.sub.1-C.sub.3)alkyl, nitro, amino, cyano, (C.sub.1-C.sub.4)alkoxycarbonyl, (C.sub.1-C.sub.3)alkylamino orcarboxy; (C.sub.1-C.sub.4)alkoxy group; C.sub.6-aryloxy selected from phenoxy or substituted phenoxy with substitution selected from halo, (C.sub.1-C.sub.4) alkyl, nitro, cyano, thiol, amino, carboxy, di(C.sub.1-C.sub.3)alkylamino; (C.sub.7-C.sub.10)aralkyloxy; vinyloxy or a substituted vinyloxy group with substitution selected from (C.sub.1-C.sub.4)alkyl, cyano, carboxy, or (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; R.sup.aR.sup.bamino(C.sub.1-C.sub.4)alkoxy group, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is(CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2 W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)alkyl, O, S, --NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3)alkyl; or R.sup.aR.sup.baminoxy group, wherein R.sup.aR.sup.bis a straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, or 1,1-dimethylethyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2 W(CH.sub.2).sub.2--wherein W is selected from --N(C.sub.1-C.sub.3)alkyl, O, S, --NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3)alkyl; and when R=R.sup.4 (CH.sub.2).sub.nCO-- and n=1-4, R.sup.4 is selected from hydrogen; amino; straight or branched(C.sub.1-C.sub.4) alkyl group selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl or 1,1-dimethylethyl; (C.sub.3-C.sub.6)cycloalkyl selected from cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl; asubstituted (C.sub.3-C.sub.6)cycloalkyl group with substitution selected from (C.sub.1-C.sub.3)alkyl, cyano, amino or (C.sub.1-C.sub.3)acyl; (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; asubstituted(C.sub.6-C.sub.10)aryl group with substitution selected from halo, (C.sub.1-C.sub.4)alkoxy, trihalo(C.sub.1-C.sub.3)alkyl, nitro, amino, cyano, (C.sub.1-C.sub.4)alkoxycarbonyl, (C.sub.1-C.sub.3)alkylamino or carboxy; (C.sub.7-C.sub.10)aralkyl; acyloxy or haloacyloxy group selected from acetyl, propionyl, chloroacetyl, trichloroacetyl, (C.sub.3-C.sub.6) cycloalkylcarbonyl, (C.sub.6-C.sub.10)aroyl selected from benzoyl or naphthoyl, halo substituted(C.sub.6-C.sub.10)aroyl, (C.sub.1-C.sub.4)alkylbenzyl or (heterocycle)-carbonyl, the heterocycle as defined hereinabove; (C.sub.1-C.sub.4)alkoxy; C.sub.6-aryloxy selected from phenoxy or substituted phenoxy with substitution selected from halo,(C.sub.1-C.sub.4)alkyl, nitro, cyano, thiol, amino, carboxy, di(C.sub.1-C.sub.3)alkylamino; (C.sub.7-C.sub.10)aralkyloxy; (C.sub.1-C.sub.3)alkylthio group selected from methylthio, ethylthio, propylthio or allylthio; C.sub.6-arylthio group selectedfrom phenylthio or substituted phenylthio with substitution selected from halo, (C.sub.1-C.sub.4)alkyl, nitro, cyano, thiol, amino, carboxy, di(C.sub.1-C.sub.3)alkylamino; C.sub.6-arylsulfonyl group selected from phenylsulfonyl or substitutedphenylsulfonyl with substitution selected from halo, (C.sub.1-C.sub.4)alkoxy, trihalo(C.sub.1-C.sub.3)alkyl, nitro, amino, cyano, (C.sub.1-C.sub.4)alkoxycarbonyl, (C.sub.1-C.sub.3) alkylamino or carboxy; (C.sub.7-C.sub.8)aralkylthio group; aheterocycle as defined hereinabove; hydroxy; mercapto; mono- or di-straight or branched chain (C.sub.1-C.sub.6)alkylamino with the alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl,2-methylbutyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 3-methylbutyl, n-hexyl, 1-methylpentyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 2-methylpentyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl or 1-methyl-1-ethylpropyl; (C.sub.2-C.sub.5)azacycloalkyl group; acarboxy(C.sub.2-C.sub.4)alkylamino group with the carboxy alkyl selected from aminoacetic acid, .alpha.-aminopropionic acid, .alpha.-aminobutyric acid and the optical isomers thereof; .alpha.-hydroxy(C.sub.1-C.sub.3)alkyl selected from hydroxymethyl,.alpha.-hydroxyethyl or .alpha.-hydroxy-1-methylethyl or .alpha.-hydroxypropyl; halo(C.sub.1-C.sub.3)alkyl group; acyl or haloacyl selected from acetyl, propionyl, chloroacetyl, trifluoroacetyl; (C.sub.3-C.sub.6) cycloalkylcarbonyl; (C.sub.6-C.sub.10)aroyl selected from benzoyl or naphthoyl; halo substituted (C.sub.6-C.sub.10)aroyl; (C.sub.1-C.sub.4)alkylbenzoyl, or (heterocycle)carbonyl, the heterocycle as defined hereinabove; (C.sub.1-C.sub.4)alkoxycarbonylamino group selectedfrom tert-butoxycarbonylamino, allyloxycarbonylamino, methoxycarbonylamino, ethoxycarbonylamino or propoxycarbonylamino; (C.sub.1-C.sub.4)alkoxycarbonyl group selected from methoxycarbonyl, ethoxycarbonyl, straight or branched propoxycarbonyl,allyloxycarbonyl or straight or branched butoxycarbonyl; R.sup.aR.sup.b-amino(C.sub.1-C.sub.4)alkoxy group wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl,1-methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6 or --(CH.sub.2).sub.2W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)-alkyl, O, S, --NH, --NOB, and B is selected from hydrogen or (C.sub.1-C.sub.3)alkyl; or R.sup.aR.sup.baminoxy group, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)-alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or--(CH.sub.2).sub.2W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)-alkyl, O, S, --NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3)alkyl, and when R=R.sup.4' (CH.sub.2).sub.nSO.sub.2-- and n=0 R.sup.4' is selected fromamino; monosubstituted amino selected from straight or branched (C.sub.1-C.sub.6)alkylamino, cyclopropylamino, cyclobutylamino, benzylamino or phenylamino; disubstituted amino selected from dimethylamino, diethylamino, ethyl(1-methylethyl)amino,monomethylbenzylamino, piperidinyl, morpholinyl, 1-imidazolyl, 1-pyrrolyl, 1-(1,2,3-triazolyl) or 4-(1,2,4-triazolyl); straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl,2-methylpropyl or 1,1-dimethylethyl; (C.sub.3-C.sub.6) cycloalkyl selected from cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl; a substituted (C.sub.3-C.sub.6)cycloalkyl group with substitution selected from (C.sub.1-C.sub.3)alkyl, cyano, amino or(C.sub.1-C.sub.3) acyl; (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; a substituted (C.sub.6-C.sub.10)aryl group with substitution selected from halo, (C.sub.1-C.sub.4)alkoxy, trihalo(C.sub.1-C.sub.3)alkyl, nitro,amino, cyano, (C.sub.1-C.sub.4)alkoxycarbonyl, (C.sub.1-C.sub.3)alkylamino or carboxy; (C.sub.7-C.sub.9)aralkyl; halo(C.sub.1-C.sub.3)alkyl group; a heterocycle as defined hereinabove; R.sup.aR.sup.b amino (C.sub.1-C.sub.4)alkoxy group, whereinR.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)-alkyl selected from methyl, ethyl, n-propyl, 1-methyl-ethyl, n-butyl, 1-methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2W--(CH.sub.2).sub.2--wherein W is selected from --N(C.sub.1-C.sub.3) alkyl, O, S, --NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3)-alkyl; or R.sup.aR.sup.b aminoxy group, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)alkyl selected frommethyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methyl-propyl, or 2-methylpropyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3) alkyl, O, S, --NH, --NOB and B isselected from hydrogen or (C.sub.1-C.sub.3) alkyl; and when R=R.sup.4' (CH.sub.2).sub.nSO.sub.2-- and n=1-4, R.sup.4' is selected from hydrogen; straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl,1-methylpropyl, 2-methyl-propyl or 1,1-dimethylethyl; (C.sub.1-C.sub.4) carboxyalkyl; (C.sub.3-C.sub.6)cycloalkyl selected from cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl; a substituted (C.sub.3-C.sub.6) cycloalkyl group with substitutionselected from (C.sub.1-C.sub.3)alkyl, cyano, amino or (C.sub.1-C.sub.3)-acyl; (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; a substituted (C.sub.6-C.sub.10)aryl group with substitution selected from halo,(C.sub.1-C.sub.4)alkoxy, tri-halo(C.sub.1-C.sub.3) alkyl, nitro, amino, cyano, (C.sub.1-C.sub.4)alkoxy-carbonyl, (C.sub.1-C.sub.3) alkylamino or carboxy; (C.sub.7-C.sub.9)aralkyl selected from benzyl, 1-phenylethyl, 2-phenylethyl or phenylpropyl; (C.sub.1-C.sub.4)alkoxy; C.sub.6-aryloxy selected from phenoxy or substituted phenoxy with substitution selected from halo, (C.sub.1-C.sub.3)alkyl, nitro, cyano, thiol, amino, carboxy, di(C.sub.1-C.sub.3) alkylamino; (C.sub.7-C.sub.10)aralkyloxy; R.sup.aR.sup.b amino (C.sub.1-C.sub.4) alkoxy, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)-alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is(CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)alkyl, O, S, --NH, or --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3)alkyl; or R.sup.aR.sup.b aminoxy group, whereinR.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2W(CH.sub.2).sub.2--wherein W is selected from --N(C.sub.1-C.sub.3)alkyl, O, S, --NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3)alkyl; (C.sub.1-C.sub.3) alkylthio selected from methylthio, ethylthio or n-propylthio; C.sub.6-arylthio selected fromphenylthio or substituted phenylthio with substitution selected from halo, (C.sub.1-C.sub.3)alkyl, nitro, cyano, thiol, amino, carboxy, di(C.sub.1-C.sub.3)alkylamino; (C.sub.7-C.sub.8) aralkylthio; a heterocycle as defined hereinabove; hydroxy; mercapto; mono- or di-straight or branched (C.sub.1-C.sub.6)alkyl- amino group with the alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, 2-methylbutyl, 1,1-dimethylpropyl,2,2-dimethylpropyl, 3-methylbutyl, n-hexyl, 1-methylpentyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 2-methylpentyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl or 1-methyl-1-ethylpropyl; halo (C.sub.1-C.sub.3) alkyl; acyl or haloacyl selected from acetyl,propionyl, chloro-acetyl, trifluoroacetyl; (C.sub.3-C.sub.6) cycloalkylcarbonyl; (C.sub.6-C.sub.10) aroyl selected from benzoyl or naphthoyl; halo substituted (C.sub.6-C.sub.10)aroyl, (C.sub.1-C.sub.4)alkylbenzoyl, or (heterocycle) carbonyl, theheterocycle as defined hereinabove; (C.sub.1-C.sub.4)alkoxycarbonyl selected from methoxycarbonyl, ethoxycarbonyl, straight or branched propoxycarbonyl, allyloxycarbonyl or straight or branched butoxycarbonyl; R.sup.5 is selected from hydrogen; straight or branched (C.sub.1-C.sub.3)alkyl selected from methyl, ethyl, n-propyl or 1-methylethyl; (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; (C.sub.7-C.sub.9) aralkyl group; a heterocycle as definedhereinabove; or --(CH.sub.2).sub.nCOOR.sup.7 where n=0-4 and R.sup.7 is selected from hydrogen; straight or branched (C.sub.1-C.sub.3)alkyl group selected from methyl, ethyl, n-propyl or 1-methylethyl; or (C.sub.6-C.sub.10)aryl group selected fromphenyl, .alpha.-naphthyl or .beta.-naphthyl; R.sup.6 is selected from hydrogen; straight or branched (C.sub.1-C.sub.3)alkyl group selected from methyl, ethyl, n-propyl or 1-methylethyl; (C.sub.6-C.sub.10)aryl group selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; (C.sub.7-C.sub.9)-aralkyl group; a heterocycle as defined hereinabove; or --(CH.sub.2).sub.nCOOR.sup.7' where n=0-4 and R.sup.7' is selected from hydrogen; straight or branched(C.sub.1-C.sub.3)alkyl selected from methyl, ethyl, n-propyl or 1-methylethyl; or (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; with the proviso that R.sup.5 and R.sup.6 cannot both be hydrogen; or R.sup.5 andR.sup.6 taken together are --(CH.sub.2).sub.2W(CH.sub.2).sub.2--, wherein W is selected from (CH.sub.2).sub.q and q=0-1, --NH, --N(C.sub.1-C.sub.3)-alkyl, --N(C.sub.1-C.sub.4) alkoxy, oxygen, sulfur or substituted congeners selected from (L or D)proline,ethyl(L or D) rolinate, morpholine, pyrrolidine or piperidine; and the pharmacologically acceptable organic and inorganic salts or metal complexes..Iaddend. .Iadd.4. A method for the treatment or control of bacterial infections in warm-blooded animals which comprises administering to said animal having a bacterial infection a pharmacologically effective amount of a compound of formula I:##STR00225## wherein X is selected from amino, NR.sup.1R.sup.2, or halogen, the halogen is selected from bromine, chlorine, fluorine or iodine, and when X is NR.sup.1R.sup.2, R.sup.1 is methyl or ethyl and R.sup.2 is methyl or ethyl; R isR.sup.4(CH.sub.2).sub.nCO--; n is 1-4; and R.sup.4 is monosubstituted or disubstitued amino selected from straight or branched (C.sub.1-C.sub.6)alkylamino with the alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl,2-methylpropyl, 1,1-dimethylethyl, 2-methylbutyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 3-methylbutyl, n-hexyl, 1-methylpentyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 2-methylpentyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl or 1-methyl-1-ethylpropyl andpharmacologically acceptable organic and inorganic salts or metal complexes..Iaddend. .Iadd.5. A method for the treatment or control of bacterial infections in warm-blooded animals which comprises administering to said animal having a bacterial infection a pharmacologically effective amount of a compound of formula I:##STR00226## wherein X is N(CH.sub.3).sub.2 and R is R.sup.4(CH.sub.2).sub.nCO-- where n=1-4 and R.sup.4 is monosubstituted or disubstituted amino selected from straight or branched (C.sub.1-C.sub.6)alkylamino, with the alkyl selected from methyl, ethyl,n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, 2-methylbutyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 3-methylbutyl, n-hexyl, 1-methylpentyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 2-methylpentyl, 1,2-dimethylbutyl,1,3-dimethylbutyl or 1-methyl-1-ethylpropyl and pharmacologically acceptable organic and inorganic salts or metal complexes..Iaddend. .Iadd.6. A method for the treatment or control of bacterial infections in warm-blooded animals which comprises administering to said animal having a bacterial infection a pharmacologically effective amount of a compound of formula I:##STR00227## wherein X is N(CH.sub.3).sub.2 and R is R.sup.4(CH.sub.2).sub.nCO-- where n is 1 and R.sup.4 is monosubstituted or disubstituted amino selected from straight or branched (C.sub.1-C.sub.6)alkylamino, with the alkyl selected from methyl,ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, 2-methylbutyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 3-methylbutyl, n-hexyl, 1-methylpentyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 2-methylpentyl,1,2-dimethylbutyl, 1,3-dimethylbutyl or 1-methyl-1-ethylpropyl and pharmacologically acceptable organic and inorganic salts or metal complexes..Iaddend. .Iadd.7. A method for the treatment or control of bacterial infections in warm-blooded animals which comprises administering to said animal having a bacterial infection a pharmacologically effective amount of a compound of formula I:##STR00228## wherein R.sup.4 is a monosubstituted straight or branched C.sub.4-alkylamino, and pharmacologically acceptable organic and inorganic salts or metal complexes..Iaddend. .Iadd.8. A method for the treatment or control of bacterial infections in warm-blooded animals caused by bacteria having the TetM and TetK resistant determinants which comprises administering to said animal a pharmacologically effective amountof a compound of the formula: ##STR00229## wherein: X is selected from amino, NR.sup.1R.sup.2 or halogen; the halogen is selected from bromine, chlorine, fluorine or iodine; R.sup.1 is selected from hydrogen, methyl, ethyl, n-propyl, 1-methylethyl,n-butyl and 1-methylpropyl; R.sup.2 is selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, and 1,1-dimethylethyl such that when X=NR.sup.1R.sup.2 and R.sup.1=hydrogen, R.sup.2=methyl, ethyl, n-propyl,1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl or 1,1-dimethylethyl; and when R.sup.1=methyl or ethyl, R.sup.2=methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl or 2-methylpropyl; and when R.sup.1=n-propyl, R.sup.2=n-propyl,1-methylethyl, n-butyl, 1-methylpropyl or 2-methylpropyl; and when R.sup.1=1-methylethyl, R.sup.2=n-butyl, 1-methylpropyl or 2-methylpropyl; and when R.sup.1=n-butyl, R.sup.2=n-butyl, 1-methylpropyl or 2-methylpropyl; and when R.sup.1=1-methylpropyl,R.sup.2=2-methylpropyl; R is selected from R.sup.4(CH.sub.2).sub.nCO-- or R.sup.4' (CH.sub.2).sub.nSO.sub.2--; and n=0-4; and when R=R.sup.4(CH.sub.2).sub.n CO-- and n=0, R.sup.4 is selected from hydrogen; amino; monosubstituted amino selected fromstraight or branched (C.sub.1-C.sub.6)alkylamino, cyclopropylamino, cyclobutylamino, benzylamino or phenylamino; disubstituted amino selected from dimethylamino, diethylamino, ethyl(1-methylethyl)amino, monomethylbenzylamino, piperidinyl, morpholinyl,1-imidazolyl, 1-pyrrolyl, 1-(1,2,3-triazolyl) or 4-(1,2,4-triazolyl); straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl or 1,1-dimethylethyl; (C.sub.3-C.sub.6)cycloalkyl selected from cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl; a substituted (C.sub.3-C.sub.6)cycloalkyl group with substitution selected from (C.sub.1-C.sub.3)alkyl, cyano, amino or (C.sub.1-C.sub.3)acyl; (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; a substituted (C.sub.6-C.sub.10)aryl group with substitution selected from halo, (C.sub.1-C.sub.4) alkoxy, trihalo(C.sub.1-C.sub.3)alkyl, nitro, amino, cyano,(C.sub.1-C.sub.4)alkoxycarbonyl, (C.sub.1-C.sub.3)alkylamino or carboxy; (C.sub.7-C.sub.9) aralkyl selected from benzyl, 1-phenylethyl, 2-phenylethyl or phenylpropyl; .alpha.-amino-(C.sub.1-C.sub.4)alkyl selected from aminomethyl, .alpha.-aminoethyl,.alpha.-aminopropyl or .alpha.-aminobutyl; carboxy (C.sub.2-C.sub.4)-alkylamino selected from aminoacetic acid, .alpha.-aminobutyric acid or .alpha.-aminopropionic acid and the optical isomers thereof; (C.sub.7-C.sub.9)aralkylamino; (C.sub.1-C.sub.4)alkoxycarbonylamino substituted (C.sub.1-C.sub.4) alkyl group; .alpha.-hydroxy(C.sub.1-C.sub.3)alkyl selected from hydroxymethyl, .alpha.-hydroxyethyl or .alpha.-hydroxy-1-methylethyl or .alpha.-hydroxypropyl; .alpha.-mercapto(C.sub.1-C.sub.3)alkyl selected from mercaptomethyl, .alpha.-mercaptoethyl, .alpha.-mercapto-1-methylethyl or .alpha.-mercaptopropyl; halo(C.sub.1-C.sub.3)alkyl group; a heterocycle selected from the group consisting of a five membered aromatic orsaturated ring with one N, O, S or Se heteroatom optionally having a benzo or pyrido ring fused thereto, a five membered aromatic ring with two N, O, S, or Se heteroatoms optionally having a benzo or pyrido ring fused thereto, a six membered aromaticring with one to three N, O, S or Se heteroatoms, or a six membered saturated ring with one or two N, O, S or Se heteroatoms and an adjacent appended O heteroatom; acyl or haloacyl group selected from acetyl, propionyl, chloroacetyl, trifluoroacetyl; (C.sub.3-C.sub.6) cycloalkylcarbonyl, (C.sub.6-C.sub.10)aroyl selected from benzoyl or naphthoyl; halo substituted (C.sub.6-C.sub.10)aroyl; (C.sub.1-C.sub.4) alkylbenzoyl, or (heterocycle)-carbonyl, the heterocycle as defined hereinabove; (C.sub.1-C.sub.4)alkoxycarbonyl selected from methoxycarbonyl, ethoxycarbonyl, straight or branched propoxycarbonyl, straight or branched butoxycarbonyl or allyloxycarbonyl; vinyl or a substituted vinyl group with substitution selected from(C.sub.1-C.sub.3) alkyl, halogen, (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl, .beta.-naphthyl, halo(C.sub.1-C.sub.3)alkyl, or a substituted (C.sub.6-C.sub.10)aryl group with substitution selected from halo, (C.sub.1-C.sub.4)-alkoxy,trihalo(C.sub.1-C.sub.3)alkyl, nitro, amino, cyano, (C.sub.1-C.sub.4)alkoxycarbonyl, (C.sub.1-C.sub.3)alkylamino or carboxy; (C.sub.1-C.sub.4)alkoxy group; C.sub.6-aryloxy selected from phenoxy or substituted phenoxy with substitution selected fromhalo, (C.sub.1-C.sub.4) alkyl, nitro, cyano, thiol, amino, carboxy, di(C.sub.1-C.sub.3)alkylamino; (C.sub.7-C.sub.10)aralkyloxy; vinyloxy or a substituted vinyloxy group with substitution selected from (C.sub.1-C.sub.4)alkyl, cyano, carboxy, or(C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; R.sup.aR.sup.bamino(C.sub.1-C.sub.4)alkoxy group, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl,1-methylethyl, n-butyl, 1-methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2 W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)alkyl, O, S, --NH, --NOB and B is selected from hydrogen or(C.sub.1-C.sub.3)alkyl; or R.sup.aR.sup.baminoxy group, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, or 1,1-dimethylethyl orR.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2 W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)alkyl, O, S, --NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3)alkyl; and when R=R.sup.4(CH.sub.2).sub.nCO-- and n=1-4, R.sup.4 is selected from hydrogen; amino; straight or branched (C.sub.1-C.sub.4) alkyl group selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl or 1,1-dimethylethyl; (C.sub.3-C.sub.6)cycloalkyl selected from cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl; a substituted (C.sub.3-C.sub.6)cycloalkyl group with substitution selected from (C.sub.1-C.sub.3)alkyl, cyano, amino or (C.sub.1-C.sub.3)acyl; (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; a substituted(C.sub.6-C.sub.10)aryl group with substitution selected from halo, (C.sub.1-C.sub.4)alkoxy, trihalo(C.sub.1-C.sub.3)alkyl, nitro, amino, cyano,(C.sub.1-C.sub.4)alkoxycarbonyl, (C.sub.1-C.sub.3)alkylamino or carboxy; (C.sub.7-C.sub.10)aralkyl; acyloxy or haloacyloxy group selected from acetyl, propionyl, chloroacetyl, trichloroacetyl, (C.sub.3-C.sub.6) cycloalkylcarbonyl,(C.sub.6-C.sub.10)aroyl selected from benzoyl or naphthoyl, halo substituted (C.sub.6-C.sub.10)aroyl, (C.sub.1-C.sub.4)alkylbenzyl or (heterocycle)-carbonyl, the heterocycle as defined hereinabove; (C.sub.1-C.sub.4)alkoxy; C.sub.6-aryloxy selected fromphenoxy or substituted phenoxy with substitution selected from halo, (C.sub.1-C.sub.4)alkyl, nitro, cyano, thiol, amino, carboxy, di(C.sub.1-C.sub.3)alkylamino; (C.sub.7-C.sub.10)aralkyloxy; (C.sub.1-C.sub.3)alkylthio group selected from methylthio,ethylthio, propylthio or allylthio; C.sub.6-arylthio group selected from phenylthio or substituted phenylthio with substitution selected from halo, (C.sub.1-C.sub.4)alkyl, nitro, cyano, thiol, amino, carboxy, di(C.sub.1-C.sub.3)alkylamino; C.sub.6-arylsulfonyl group selected from phenylsulfonyl or substituted phenylsulfonyl with substitution selected from halo, (C.sub.1-C.sub.4)alkoxy, trihalo(C.sub.1-C.sub.3)alkyl, nitro, amino, cyano, (C.sub.1-C.sub.4)alkoxycarbonyl, (C.sub.1-C.sub.3)alkylamino or carboxy; (C.sub.7-C.sub.8)aralkylthio group; a heterocycle as defined hereinabove; hydroxy; mercapto; mono- or di-straight or branched chain (C.sub.1-C.sub.6)alkylamino with the alkyl selected from methyl, ethyl, n-propyl,1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, 2-methylbutyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 3-methylbutyl, n-hexyl, 1-methylpentyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 2-methylpentyl, 1,2-dimethylbutyl,1,3-dimethylbutyl or 1-methyl-1-ethylpropyl; (C.sub.2-C.sub.5)azacycloalkyl group; a carboxy(C.sub.2-C.sub.4)alkylamino group with the carboxy alkyl selected from aminoacetic acid, .alpha.-aminopropionic acid, .alpha.-aminobutyric acid and the opticalisomers thereof; .alpha.-hydroxy(C.sub.1-C.sub.3)alkyl selected from hydroxymethyl, .alpha.-hydroxyethyl or .alpha.-hydroxy-1-methylethyl or .alpha.-hydroxypropyl; halo(C.sub.1-C.sub.3)alkyl group; acyl or haloacyl selected from acetyl, propionyl,chloroacetyl, trifluoroacetyl; (C.sub.3-C.sub.6) cycloalkylcarbonyl; (C.sub.6-C.sub.10)aroyl selected from benzoyl or naphthoyl; halo substituted (C.sub.6-C.sub.10)aroyl; (C.sub.1-C.sub.4)alkylbenzoyl, or (heterocycle)carbonyl, the heterocycle asdefined hereinabove; (C.sub.1-C.sub.4)alkoxycarbonylamino group selected from tert-butoxycarbonylamino, allyloxycarbonylamino, methoxycarbonylamino, ethoxycarbonylamino or propoxycarbonylamino; (C.sub.1-C.sub.4)alkoxycarbonyl group selected frommethoxycarbonyl, ethoxycarbonyl, straight or branched propoxycarbonyl, allyloxycarbonyl or straight or branched butoxycarbonyl; R.sup.aR.sup.b-amino(C.sub.1-C.sub.4)alkoxy group wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)alkylselected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6 or --(CH.sub.2).sub.2W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)-alkyl, O, S, --NH,--NOB, and B is selected from hydrogen or (C.sub.1-C.sub.3)alkyl; or R.sup.aR.sup.baminoxy group, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)-alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl,2-methylpropyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)-alkyl, O, S, --NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3)alkyl, and when R=R.sup.4'(CH.sub.2).sub.nSO.sub.2-- and n=0 R.sup.4' is selected from amino; monosubstituted amino selected from straight or branched (C.sub.1-C.sub.6)alkylamino, cyclopropylamino, cyclobutylamino, benzylamino or phenylamino; disubstituted amino selected fromdimethylamino, diethylamino, ethyl(1-methylethyl)amino, monomethylbenzylamino, piperidinyl, morpholinyl, 1-imidazolyl, 1-pyrrolyl, 1-(1,2,3-triazolyl) or 4-(1,2,4-triazolyl); straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl,n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl or 1,1-dimethylethyl; (C.sub.3-C.sub.6) cycloalkyl selected from cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl; a substituted (C.sub.3-C.sub.6)cycloalkyl group with substitutionselected from (C.sub.1-C.sub.3)alkyl, cyano, amino or (C.sub.1-C.sub.3) acyl; (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; a substituted (C.sub.6-C.sub.10)aryl group with substitution selected from halo,(C.sub.1-C.sub.4)alkoxy, trihalo(C.sub.1-C.sub.3)alkyl, nitro, amino, cyano, (C.sub.1-C.sub.4)alkoxycarbonyl, (C.sub.1-C.sub.3)alkylamino or carboxy; (C.sub.7-C.sub.9)aralkyl; halo(C.sub.1-C.sub.3)alkyl group; a heterocycle as defined hereinabove; R.sup.aR.sup.b amino (C.sub.1-C.sub.4)alkoxy group, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)-alkyl selected from methyl, ethyl, n-propyl, 1-methyl-ethyl, n-butyl, 1-methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is(CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2W--(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3) alkyl, O, S, --NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3)-alkyl; or R.sup.aR.sup.b aminoxy group, whereinR.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2W(CH.sub.2).sub.2--wherein W is selected from --N(C.sub.1-C.sub.3) alkyl, O, S, --NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3) alkyl; and when R=R.sup.4' (CH.sub.2).sub.nSO.sub.2-- and n=1-4, R.sup.4' is selected from hydrogen; straight or branched(C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methyl-propyl or 1,1-dimethylethyl; (C.sub.1-C.sub.4) carboxyalkyl; (C.sub.3-C.sub.6)cycloalkyl selected from cyclopropyl, cyclobutyl, cyclopentylor cyclohexyl; a substituted (C.sub.3-C.sub.6) cycloalkyl group with substitution selected from (C.sub.1-C.sub.3)alkyl, cyano, amino or (C.sub.1-C.sub.3)-acyl; (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; asubstituted (C.sub.6-C.sub.10)aryl group with substitution selected from halo, (C.sub.1-C.sub.4)alkoxy, tri-halo(C.sub.1-C.sub.3) alkyl, nitro, amino, cyano, (C.sub.1-C.sub.4)alkoxy-carbonyl, (C.sub.1-C.sub.3) alkylamino or carboxy; (C.sub.7-C.sub.9)aralkyl selected from benzyl, 1-phenylethyl, 2-phenylethyl or phenylpropyl; (C.sub.1-C.sub.4)alkoxy; C.sub.6-aryloxy selected from phenoxy or substituted phenoxy with substitution selected from halo, (C.sub.1-C.sub.3)alkyl, nitro,cyano, thiol, amino, carboxy, di(C.sub.1-C.sub.3) alkylamino; (C.sub.7-C.sub.10)aralkyloxy; R.sup.aR.sup.b amino (C.sub.1-C.sub.4) alkoxy, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)-alkyl selected from methyl, ethyl, n-propyl,1-methylethyl, n-butyl, 1-methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is (CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)alkyl, O, S, --NH, or --NOB and B is selected from hydrogen or(C.sub.1-C.sub.3)alkyl; or R.sup.aR.sup.b aminoxy group, wherein R.sup.aR.sup.b is a straight or branched (C.sub.1-C.sub.4)alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, or 2-methylpropyl or R.sup.aR.sup.b is(CH.sub.2).sub.m, m=2-6, or --(CH.sub.2).sub.2W(CH.sub.2).sub.2-- wherein W is selected from --N(C.sub.1-C.sub.3)alkyl, O, S, --NH, --NOB and B is selected from hydrogen or (C.sub.1-C.sub.3)alkyl; (C.sub.1-C.sub.3) alkylthio selected from methylthio,ethylthio or n-propylthio; C.sub.6-arylthio selected from phenylthio or substituted phenylthio with substitution selected from halo, (C.sub.1-C.sub.3)alkyl, nitro, cyano, thiol, amino, carboxy, di(C.sub.1-C.sub.3)alkylamino; (C.sub.7-C.sub.8)aralkylthio; a heterocycle as defined hereinabove; hydroxy; mercapto; mono- or di-straight or branched (C.sub.1-C.sub.6)alkyl- amino group with the alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl,1,1-dimethylethyl, 2-methylbutyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 3-methylbutyl, n-hexyl, 1-methylpentyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 2-methylpentyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl or 1-methyl-1-ethylpropyl; halo(C.sub.1-C.sub.3) alkyl; acyl or haloacyl selected from acetyl, propionyl, chloro-acetyl, trifluoroacetyl; (C.sub.3-C.sub.6) cycloalkylcarbonyl; (C.sub.6-C.sub.10) aroyl selected from benzoyl or naphthoyl; halo substituted (C.sub.6-C.sub.10)aroyl,(C.sub.1-C.sub.4)alkylbenzoyl, or (heterocycle) carbonyl, the heterocycle as defined hereinabove; (C.sub.1-C.sub.4)alkoxycarbonyl selected from methoxycarbonyl, ethoxycarbonyl, straight or branched propoxycarbonyl, allyloxycarbonyl or straight orbranched butoxycarbonyl; R.sup.5 is selected from hydrogen; straight or branched (C.sub.1-C.sub.3)alkyl selected from methyl, ethyl, n-propyl or 1-methylethyl; (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; (C.sub.7-C.sub.9) aralkyl group; a heterocycle as defined hereinabove; or --(CH.sub.2).sub.nCOOR.sup.7 where n=0-4 and R.sup.7 is selected from hydrogen; straight or branched (C.sub.1-C.sub.3)alkyl group selected from methyl, ethyl, n-propyl or1-methylethyl; or (C.sub.6-C.sub.10)aryl group selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; R.sup.6 is selected from hydrogen; straight or branched (C.sub.1-C.sub.3)alkyl group selected from methyl, ethyl, n-propyl or 1-methylethyl; (C.sub.6-C.sub.10)aryl group selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; (C.sub.7-C.sub.9)-aralkyl group; a heterocycle as defined hereinabove; or --(CH.sub.2).sub.nCOOR.sup.7' where n=0-4 andR.sup.7' is selected from hydrogen; straight or branched (C.sub.1-C.sub.3)alkyl selected from methyl, ethyl, n-propyl or 1-methylethyl; or (C.sub.6-C.sub.10)aryl selected from phenyl, .alpha.-naphthyl or .beta.-naphthyl; with the proviso that R.sup.5and R.sup.6 cannot both be hydrogen; or R.sup.5 and R.sup.6 taken together are --(CH.sub.2).sub.2W(CH.sub.2).sub.2--, wherein W is selected from (CH.sub.2).sub.q and q=0-1, --NH, --N(C.sub.1-C.sub.3)-alkyl, --N(C.sub.1-C.sub.4) alkoxy, oxygen, sulfur orsubstituted congeners selected from (L or D)proline, ethyl(L or D)prolinate, morpholine, pyrrolidine or piperidine; and the pharmacologically acceptable organic and inorganic salts or metal complexes..Iaddend. .Iadd.9. A method for the treatment or control of bacterial infections in warm-blooded animals caused by bacteria having the TetM and TetK resistant determinants which comprises administering to said animal a pharmacologically effective amountas of compound of formula I: ##STR00230## wherein X is selected from amino, NR.sup.1R.sup.2, or halogen, the halogen is selected from bromine, chlorine, fluorine or iodine, and when X is NR.sup.1R.sup.2, R.sup.1 is methyl or ethyl and R.sup.2 is methylor ethyl; R is R.sup.4(CH.sub.2).sub.nCO--; n is 1-4; and R.sup.4 is monosubstituted or disubstituted amino selected from straight or branched chain (C.sub.1-C.sub.6)alkylamino with the alkyl selected from methyl, ethyl, n-propyl, 1-methylethyl,n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, 2-methylbutyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 3-methylbutyl, n-hexyl, 1-methylpentyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 2-methylpentyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl or1-methyl-1-ethylpropyl and pharmacologically acceptable organic and inorganic salts or metal complexes..Iaddend. .Iadd.10. A method for the treatment or control of bacterial infections in warm-blooded animals caused by bacteria having the TetM and TetK resistant determinants which comprises administering to said animal a pharmacologically effective amountas of compound of formula I: ##STR00231## wherein X is N(CH.sub.3).sub.2 and R is R.sup.4(CH.sub.2).sub.nCO-- where n=1-4 and R.sup.4 is monosubstituted or disubstituted amino selected from straight or branched (C.sub.1-C.sub.6)alkylamino, with the alkylselected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, 2-methylbutyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 3-methylbutyl, n-hexyl, 1-methylpentyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl,2-methylpentyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl or 1-methyl-1-ethylpropyl and pharmacologically acceptable organic and inorganic salts or metal complexes..Iaddend. .Iadd.11. A method for the treatment or control of bacterial infections in warm-blooded animals caused by bacteria having the TetM and TetK resistant determinants which comprises administering to said animal a pharmacologically effective amountas of compound of formula I: ##STR00232## wherein X is N(CH.sub.3).sub.2and R is R.sup.4(CH.sub.2).sub.nCO-- where n is 1 and R.sup.4 is monosubstituted or disubstituted amino selected from straight or branched (C.sub.1-C.sub.6)alkylamino, with the alkylselected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, 2-methylbutyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 3-methylbutyl, n-hexyl, 1-methylpentyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl,2-methylpentyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl or 1-methyl-1-ethylpropyl and pharmacologically acceptable organic and inorganic salts or metal complexes..Iaddend. .Iadd.12. A method for the treatment or control of bacterial infections in warm-blooded animals caused by bacteria having the TetM and TetK resistant determinants which comprises administering to said animal a pharmacologically effective amountas of compound of formula I: ##STR00233## wherein R.sup.4 is a monosubstituted straight or branched C.sub.4-alkylamino, and pharmacologically acceptable organic and inorganic salts or metals complexes..Iaddend. Description:       Recently Added Patents Demolition tool Electromagnetic scanning imager Electronic paintball marker Electromagnetic noise suppressor, structure with electromagnetic noise suppressing function, and method of manufacturing the same Methods and devices for regulating traffic on a network Hologram reproduction apparatus and hologram reproduction method Mechanism for retaining a stack of sheets in a compiler tray, such as for automatic stapling   Randomly Featured Patents Spinner basket having labyrinth ring and method for using same Analog to digital converter with bandwidth tuning circuit Battery Compositions and process Power control circuit for a radio frequency transmitter Portable tar heating and melting apparatus Device for separably assembling two enclosures of a cut-out apparatus containing fluid under pressure Double oscillator battery powered flashing superluminescent light emitting diode safety warning light Polysulfide-based polyurethane sealant for insulating glass Very fine grain field programmable gate array architecture and circuitry © 2006. PatentGenius. All Rights Reserved.